Innospec earnings were $19.3M for the trailing 12 months ending Jun 30, 2025, with -87.2% growth year over year. The latest IOSP earnings report on Jun 30, 2025 announced Q2 2025 earnings of $23.5M, down 28.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IOSP reported annual earnings of $35.6M, with -74.4% growth.
IOSP past earnings growth
How has IOSP's earnings growth performed historically?
On IOSP's earnings call on Invalid Date, Innospec (NASDAQ: IOSP) reported Q2 2025 earnings per share (EPS) of $0.94, up 24.8% year over year. Total IOSP earnings for the quarter were $23.50 million. In the same quarter last year, Innospec's earnings per share (EPS) was $1.25.
As of the last Innospec earnings report, Innospec is currently profitable. Innospec's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $19.30 million, a 87.1% decrease year over year.
What was IOSP's earnings growth in the past year?
As of Innospec's earnings date in Invalid Date, Innospec's earnings has grown -87.19% year over year. This is 93.34 percentage points lower than the US Specialty Chemicals industry earnings growth rate of 6.15%. IOSP earnings in the past year totalled $19.30 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.